Zylox Medical Device Co Sustainability Profile
Zylox Medical Device Co., a leading innovator in the medical technology sector, is headquartered in China (CN) and operates extensively across Asia and Europe. Founded in 2010, the company has rapidly established itself as a key player in the development of advanced medical devices, particularly in the fields of minimally invasive surgery and diagnostic imaging. Zylox is renowned for its cutting-edge products, including state-of-the-art endoscopic systems and precision surgical instruments, which are designed to enhance patient outcomes and streamline surgical procedures. The company’s commitment to quality and innovation has earned it numerous accolades, solidifying its position as a trusted name in the medical device industry. With a focus on research and development, Zylox continues to push the boundaries of technology, ensuring it remains at the forefront of medical advancements.
DitchCarbon Score
How does Zylox Medical Device Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zylox Medical Device Co's score of 34 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zylox Medical Device Co's reported carbon emissions
In 2024, Zylox Medical Device Co, headquartered in CN, reported total carbon emissions of approximately 2,831,840 kg CO2e. This figure comprises 233,140 kg CO2e from Scope 1 emissions and 2,598,700 kg CO2e from Scope 2 emissions. The company has shown a slight decrease in emissions from 2023, where total emissions were approximately 3,291,740 kg CO2e, with Scope 1 at 279,920 kg CO2e and Scope 2 at 3,011,820 kg CO2e. Zylox has not disclosed any Scope 3 emissions data, and there are currently no specific reduction targets or climate pledges outlined in their reports. The absence of documented reduction initiatives suggests that the company may be in the early stages of developing a comprehensive climate strategy. Overall, Zylox Medical Device Co's emissions data reflects a commitment to transparency, although further action may be necessary to establish clear climate commitments and reduction targets in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 20,840 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 1,384,300 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
How Carbon Intensive is Zylox Medical Device Co's Industry?
How Carbon Intensive is Zylox Medical Device Co's Location?
Zylox Medical Device Co's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zylox Medical Device Co has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
GE HealthCare
Zimmer Biomet
Siemens Healthineers AG
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.